symbol,price,beta,volAvg,mktCap,lastDiv,range,changes,companyName,currency,cik,isin,cusip,exchange,exchangeShortName,industry,website,description,ceo,sector,country,fullTimeEmployees,phone,address,city,state,zip,dcfDiff,dcf,image,ipoDate,defaultImage,isEtf,isActivelyTrading,isAdr,isFund
OVIT,0.0002,-52.696224,5290,558338,0,1.0E-4-0.0015,0,"OncoVista Innovative Therapies, Inc.",USD,,,,Other OTC,PNK,Biotechnology,https://www.oncovista.com,"OncoVista Innovative Therapies, Inc., a biopharmaceutical company, develops targeted anticancer therapies by utilizing tumor-associated biomarkers. The company's product candidates include Cordycepin (OVI-123), which is in Phase I/II clinical trials for the treatment of refractory TdT positive leukemias; and L-Nucleoside Conjugates (OVI-117) that is under pre-clinical development for the treatment of colon cancer. The company was founded in 2004 and is based in San Antonio, Texas.",Dr. Alexander L. Weis Ph.D.,Healthcare,US,2,210-677-6000,14785 Omicron Drive,San Antonio,TX,78245,,0,https://financialmodelingprep.com/image-stock/OVIT.png,2007-10-26,True,False,False,False,False
